NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that clinical data from a ...
NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug ...
Permanent HCPCS code granted following U.S. FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ Direct Visualization System (DVS), together referred to as LumiSystem™, with commercial ...
Hunterdon Medical Center and The Institute for Advanced Reconstruction proudly announce being the first healthcare providers on the East Coast to use the Lumicell® Direct Visualization System for ...
As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...
NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the U.S. commercial ...
Massachusetts-based Lumicell has received a Phase I Small Business Innovation Research contract from the National Cancer Institute (NCI), for development of an endoscopic imaging system for diagnosis ...